Skip to content
Precision for Medicine
Contact Us
Clinical Trial Management Services

Clinical Trial Management Services

Global clinical trial management for life-changing therapies

From first patient in to last patient out, Precision for Medicine delivers seamless clinical trial management that accelerates timelines and ensures quality. Our global team, advanced infrastructure, and proprietary technologies guide every step, helping you overcome complexity and achieve your development goals.

Your Trusted Global CRO Partner for End-to-End Clinical Trial Management

3500
Clinical Research Professionals Deep expertise for every phase
40
Global Locations Reach and scalability where you need it
20
Years of Experience Trusted by leading innovators worldwide
600
Global Trials Proven success across key therapeutic areas

Award-Winning Clinical Trial Management Services

Precision for Medicine combines expert teams, global reach, and advanced technologies to simplify complexity and deliver results. By transforming data into actionable insights and applying agile processes, we empower every phase of your trial—from concept to completion—to achieve milestones faster and set new industry standards.
  • Clinical Trial Strategy & Planning
  • Accelerated Study Start Up
  • End-to-End Clinical Trial Execution
  • Seamless Regulatory Submission

How We Deliver Success

Integrating regulatory expertise, global development strategy, and operational excellence ensure seamless trial execution and expedited regulatory submissions. All of this is powered by a robust quality and technology platform that enables real-time risk mitigation and proactive quality management, giving you confidence at every stage.

 

Speak with an expert

  • Regulatory Expertise

    Regulatory Expertise

    Integrating regulatory, clinical, and medical expertise to guide your program from IND through NDA. Our strategies are led by ex-FDA experts, ensuring compliance and accelerating approvals.

  • Strategic Planning

    Strategic Planning

    Global reach with local expertise. We coordinate global and regional hubs, manage country-specific regulatory planning, and optimize site selection for faster, smarter trial start-up.

  • Operational Excellence

    Operational Excellence

    Data-driven clinical execution supported by strong site partnerships. Standardized global processes, centralized monitoring, and real-time dashboards keep your trial on track and on time.

  • Governance, Quality & Insight

    Governance, Quality & Insight

    Multi-tiered governance structures backed by real-time analytics and risk-based monitoring. Continuous improvement ensures quality and mitigates risk throughout your trial.

Advancing Outcomes at Every Stage

With 42.5% of our work in early-phase development and 57.5% in late-phase studies, we deliver expertise across the entire clinical lifecycle. From innovative trial design and regulatory strategy to large-scale execution, we handle complexity and accelerate timelines, helping you achieve success from IND through NDA.
 
  • Discover Early Phase Excellence
    clinical trial patient doctor

    Early Phase Excellence

    Expert trial design and biomarker strategies to optimize early-phase studies. Navigate regulatory pathways and accelerate start-up for faster insights and smarter decisions.

    Explore
  • Discover Late Phase Success
    patient on bed clinical

    Late Phase Success

    Proven global capabilities to manage large-scale trials with precision. Our integrated approach ensures compliance, quality, and efficiency, driving success from pivotal studies to submission.

    Explore

  • Next-Gen Technologies and Data Infrastructure That Accelerate Trial Insights

    Industry-leading platforms like Veeva and proprietary solutions such as Cliniscope and Metavate enable data-driven trial execution and improve efficiencies at every stage of development. Our advanced technology ecosystem transforms complexity into actionable insights, empowering smarter decisions and faster progress.

  • ISSISE data flow
    Explore

    Integrated Clinical Trial Management

    Partnership with Veeva for CTMS, EDC, and eTMF capabilities. Expertise with leading EDC platforms and next-generation clinical trial technology providers.

    Explore
  • Centralized Monitoring and Risk-based Quality Management
    Explore

    Clinscope

    Real-time safety and trial insights with CliniscopeTM. Centralized monitoring and RBQM model for proactive risk management.
    Explore
  • Automated Clinical Data transformation
    Explore

    Metavate

    Automated, metadata-driven clinical data transformation to expedite regulatory submissions. MetavateTM enhances biostatistics and statistical programming capabilities, helping sponsors accelerate timelines and reduce time to market.

    Explore
  • Decentralized Clinical Trials
    Explore

    Decentralized Clinical Trials

    30+ specialist vendors partnering with Precision around the world for DCT execution. Expertise in rare and pediatric study delivery ensures flexibility and patient-centric solutions.

    Explore
  • AI and analytics driven trial optimization
    Explore

    AI-driven Trial Optimization

    AI-forward strategy and smart automation across trial stages to enhance efficiencies and drive smart outcomes.
    Explore

Global Clinical Trial Management Case Studies

  • Read Case Study

    Case Study - ONCOLOGY

    Conducting Autologous Cell Therapy Research Across Continents

    This Phase 1–2 autologous cell therapy study spanned sites across the U.S. and Europe, each operating under distinct regulatory frameworks.
    Engaged to oversee trial execution, discover how Precision for Medicine coordinated complex cross-border logistics and site readiness, achieving zero sample or IP loss throughout the program.
    • 3
      continents
    • 0
      sample loss
    Read Case Study
  • Read Case Study

    Case Study - ONCOLOGY

    Phase 3 Prostate Cancer Case Study: Radiopharm Imaging at Scale

    This Phase 3 PSMA-targeted imaging trial in prostate cancer, ran across the U.S. and Canada, required on-time administration of a short-lived radiopharmaceutical within hours of delivery.  Read how this study scaled while maintaining dose-on-time compliance, zero site shutdowns, and robust imaging data quality.

    • 380+
      participants
    • 0
      Data quality issues
    Read Case Study
CRO Leadership Awards 2024

Award-winning clinical trial management services

Precision for Medicine’s recognition in the 2024 CRO Leadership Awards across every category reflects more than excellence—it underscores our commitment to advancing your clinical trials. Our award-winning expertise delivers not only superior trial management but also a shared mission to bring transformative therapies to patients worldwide.

See how consistent industry recognition demonstrates our dedication to quality, innovation, and success in clinical trial management.

Request a proposal

Deep experience with debilitating disease and unique modalities

 

We understand that every development pathway begins and ends with a patient. Supporting our partners in delivering innovative treatments is our purpose. Leverage our proven expertise across complex therapeutic areas and advanced modalities to bring transformative therapies to those who need them most.

Oncology Explore Rare Diseases Explore Autoimmune Explore Gene Therapy Explore Cell Therapy Explore

Frequently Asked Questions

How many countries can Precision for Medicine support simultaneously?

Precision delivers truly global trial management, supporting studies across North America, Europe, Asia-Pacific, and Latin America through an integrated network of local experts and regulatory specialists.

We routinely manage multi-country, multi-regional oncology and rare-disease trials, ensuring harmonized trial conduct, consistent data quality, and rapid study start-up across all participating regions.

What is the typical timeline for first-patient-in in multi-region trials?

Timelines vary by indication and geography, but Precision focuses on accelerating feasibility, regulatory submissions, and site activation to expedite FPI timelines.

Our global start-up model—supported by predictive feasibility, country-specific regulatory intelligence, and centralized project governance, typically enables FPI within 3–6 months in priority markets.

How do you manage global regulatory submissions and country-specific compliance?

Our regulatory operations team manages end-to-end global submissions, from IND/CTA strategy and dossier preparation to ongoing Health Authority engagement across each region.

We combine local regulatory expertise, global SOPs, and centralized quality oversight to ensure every country meets its specific requirements, reducing delays, preventing rework, and ensuring inspection-readiness throughout the trial.

How do you manage patient recruitment and retention across regions?

Precision uses data-driven enrollment forecasting, site-level analytics, and real-time centralized monitoring to identify risks early and optimize recruitment strategies.

Our teams work closely with investigators to implement country-specific outreach plans, streamline pre-screening, and support protocol adherence — all of which strengthen retention, diversity, and time-to-enrollment.

What is your monitoring model for global trials (remote vs on-site)?

Every trial is different and we tailor the monitoring strategy to align with the needs of each program. Precision also offers a hybrid monitoring model that is built on: 

  • Centralized monitoring for real-time insight into data quality and patient safety
  • Risk-based approaches informed by analytics to focus resources where they matter most
  • Flexible remote and on-site visits aligned with regulatory expectations
This approach provides faster detection of issues, lowers burden on sites, and maintains data integrity across regions.

Can you support decentralised or hybrid trials across multiple regions?

Yes. We design and manage decentralized and hybrid trial models across multiple regions, leveraging remote assessments, digital tools, home-health services, and flexible visit schedules.

Our operational framework ensures regional regulatory compliance, data integration, and consistent patient experience, making complex global DCTs feasible, scalable, and audit-ready. 

Read our latest Precision insights

Stay updated with the latest insights in statistical programming and automation through our blog. 

Explore the blog
Read: Early‑Phase Autoimmune Drug Development: Trial Design, Biomarkers and Statistical Strategies Early‑Phase Autoimmune Drug Development: Trial Design, Biomarkers and Statistical Strategies

Clinical Trials

Early‑Phase Autoimmune Drug Development: Trial Design, Biomarkers and Statistical Strategies

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=213698206365, hs_child_table_id=0, hs_updated_at=1780680681226, hs_published_at=1780680684943, description=Rui F. Duarte‑Lopes is a senior biostatistics leader with over 31 years of international experience across biopharmaceutical, biotechnology, and CRO sectors. He provides strategic statistical oversight, ensuring rigorous, high‑quality, and decision‑focused delivery aligned with sponsor and regulatory expectations. He has more than 12 years of CRO experience supporting Phase I–IV clinical trials and has held roles including Lead Statistician, Project Lead, and Senior Manager. His therapeutic experience includes oncology and autoimmune diseases, notably lupus erythematosus, Crohn's disease and rheumatoid arthritis. Specializing in oncology over the past six years, Rui focuses on advanced solid tumors and early‑phase studies, contributing to study design, interim analyses, and data‑driven decision frameworks., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Rui%20F%20Duarte-Lopes.jpg',altText='Rui F Duarte-Lopes',fileId=213695319705}, lastname=Duarte-Lopes, hs_initial_published_at=1779886328878, hs_created_by_user_id=26433386, hs_created_at=1779886165792, hs_is_edited=false, hs_deleted_at=0, name=Rui F, job=Senior Manager, Biostatistics, slug=rui-f-duarte-lopes, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Rui F Duarte-Lopes avatar

    Rui F Duarte-Lopes
Discover
Read: Case Study: Advancing IHC Assays from RUO to Clinical Trials and CDx Case Study: Advancing IHC Assays from RUO to Clinical Trials and CDx

Assays - Oncology

Case Study: Advancing IHC Assays from RUO to Clinical Trials and CDx

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778874, hs_child_table_id=0, hs_updated_at=1765824406763, hs_published_at=1780680684943, description=Kennon Daniels is a scientific and regulatory in vitro diagnostic authority, specializing in the development of US regulatory strategies and FDA marketing submissions for IVD assays and instruments. Her expertise spans all aspects of product development, analytical and clinical trial protocol designs, Q-Submissions, IDEs, de novos, 510(k)s, and pre-market approval platforms., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Kennon%20Daniels.webp',altText='Kennon Daniels',fileId=165893120790}, linkedin=https://www.linkedin.com/in/kennon-daniels-ph-d-84a90b6, hs_name=, hs_path=, lastname=Daniels, PhD, hs_initial_published_at=1775839468505, hs_created_at=1709645745105, hs_is_edited=false, hs_deleted_at=0, name=Kennon, position=Vice President, IVD Regulatory Consulting, job=, slug=kennon-daniels, email=, hs_updated_by_user_id=26433386}, second={hs_id=164426546714, hs_child_table_id=0, hs_updated_at=1778171432595, hs_published_at=1780680684943, description=Angélique Heckmann, PhD is a people‑driven leader who combines scientific expertise and business acumen with a strong foundation in human values. With a background in therapeutic drug development and an MBA‑shaped strategic mindset, she focuses on building meaningful, long‑term relationships with teams, partners, and clients. By bridging science and strategy, she supports informed decision‑making, fosters collaboration, and helps translate innovation into real‑world impact—always guided by a shared purpose: advancing solutions that ultimately improve patients’ lives, avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/angelique-1.png',altText='angelique-1',fileId=194126030110}, lastname=Heckmann, PhD, hs_initial_published_at=1713174153602, hs_created_by_user_id=62155952, hs_created_at=1713172107894, hs_is_edited=false, hs_deleted_at=0, name=Angelique, job=Regional Vice President, Translational Business Solutions, slug=angelique-heckmann, hs_updated_by_user_id=26433386}, third={}})
  • Kennon D. avatar

    Kennon D.
  • Angelique H. avatar

    Angelique H.
Discover

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

  • Discover Explore
    clinical-trial-support

    Global CRO Services

    A recognized leader in oncology and rare diseases with rich experience in complex trials

    Explore
  • Discover Explore
    specialty-lab-services

    Laboratory
    Services

    Experts in translational and biomarker sciences with worldwide specialty labs and central lab services that are enabling breakthroughs.

    Explore
Loading...